Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001415889-21-003544

Options or other derivatives

  • Director acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Rotunno Mary L. Director 2021-07-06 Grant or award · Stock Option (Right to Buy) +75,000 75,000 D
Loading xslF345X03/form4-07072021_010752.xml…